Disease-Modifying Treatment in Progressive Multiple Sclerosis

被引：0
|
作者：
John Robert Ciotti
Anne Haney Cross
机构：
[1] Washington University in St. Louis,
来源：
Current Treatment Options in Neurology | 2018年 / 20卷
关键词：
Progressive multiple sclerosis; Disease-modifying therapy; Neuroprotection; Remyelination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Disease-Modifying Treatment in Progressive Multiple Sclerosis
    Ciotti, John Robert
    Cross, Anne Haney
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2018, 20 (05)
  • [2] Disease-modifying treatment of secondary progressive multiple sclerosis
    Hoffmann, Olaf
    Gold, Ralf
    NERVENARZT, 2021, 92 (10): : 1052 - 1060
  • [3] Disease-modifying treatments for progressive multiple sclerosis
    Comi, Giancarlo
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 1428 - 1436
  • [4] Progressive Multifocal Leukoencephalopathy as a Complication of Disease-modifying Treatment of Multiple Sclerosis
    M. N. Zakharova
    E. V. Lysogorskaia
    M. V. Ivanova
    I. A. Kochergin
    Y. E. Korzhova
    Human Physiology, 2019, 45 (8) : 863 - 868
  • [5] Current Disease-Modifying Treatment of Multiple Sclerosis
    Derwenskus, Joy
    MOUNT SINAI JOURNAL OF MEDICINE, 2011, 78 (02): : 161 - 175
  • [6] Stopping disease-modifying therapy in relapsing and progressive multiple sclerosis
    Hartung, Hans-Peter
    Meuth, Sven G.
    Miller, Deborah M.
    Comi, Giancarlo
    CURRENT OPINION IN NEUROLOGY, 2021, 34 (04) : 598 - 603
  • [7] The effect of disease-modifying treatments on conversion to secondary progressive multiple sclerosis
    Brown, J. W. L.
    Coles, A.
    Horakova, D.
    Havrdova, E.
    Trojano, M.
    Izquierdo, G.
    Prat, A.
    Girard, M.
    Hupperts, R.
    Van Pesch, V.
    Ferraro, D.
    Alroughani, R.
    Bergamaschi, R.
    Pucci, E.
    Iuliano, G.
    Lechner-Scott, J.
    Spelman, T.
    Jokubaitis, V.
    Ramo-Tello, C.
    Spitaleri, D.
    Granella, F.
    Solaro, C.
    Ampapa, R.
    Deri, N.
    McCombe, P.
    Petersen, T.
    Van Wijmeersch, B.
    Prevost, J.
    Sanchez-Menoyo, J. L.
    Soysal, A.
    Barnett, M.
    Moore, F.
    Rice, C.
    Scolding, N.
    Wilkins, A.
    McGuigan, C.
    Hutchinson, M.
    Ziemssen, T.
    Pearson, O.
    Harding, K.
    Duquette, P.
    Lugaresi, A.
    Grammond, P.
    Grand'Maison, F.
    Terzi, M.
    Shaygannejad, V.
    Sola, P.
    Butzkueven, H.
    Kalincik, T.
    Robsertson, N.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 32 - 34
  • [8] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [9] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    NEUROLOGY, 2011, 77 (04) : E26 - E26
  • [10] Disease-modifying therapy for multiple sclerosis
    Holmoy, Trygve
    Myhr, Kjell-Morten
    Bo, Lars
    Nygaard, Gro Owren
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2021, 141 (08) : 723 - 726
12345